Theranos' Holmes, Balwani Slammed By SEC For 'Massive Fraud'
Executive Summary
In another blow from the US government, securities regulators have severely penalized Theranos and its cofounder, Elizabeth Holmes, for allegedly lying to investors to raise funds.
You may also be interested in...
Attorneys Mull Takeaways From Conviction Of Theranos Founder Holmes
Elizabeth Holmes has been convicted on four counts of investor fraud. Two attorneys who followed the case spoke to Medtech Insight about what happened – and what it could mean for industry as a whole.
Babson Diagnostics Plans To Deliver What Theranos Could Not
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.
Theranos Faces Two Potential Class Action Suits
Two consumers have filed attempted class action suits against Theranos that claim the lab-testing company's advertising misled consumers as to the safety and reliability of its products. The company denies the allegations. Theranos is facing exclusion from CMS over repeated lab problems.